Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Kruppel-like factor 10 (KLF10) as a biomarker of endothelial progenitor cell dysfunction

Kruppel-like factor 10 (KLF10) as a biomarker of endothelial progenitor cell dysfunction

US Patent 9500658 · Granted Nov 22, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells a2025
Replication-competent attenuated chimeric VSV vectors encoding immunogenic SARS-2025
Use of small molecule inhibitors to KLF10 for modulation of T regulatory cells a2022
Enhancing dermal wound healing by downregulating microRNA-26a2019
Detection of organ rejection2017
Methods of treating vascular inflammatory disorders2017
Methods of using microRNA-26a to promote angiogenesis2016
Methods of treating vascular inflammatory disorders2014
Diagnosing, monitoring and treating inflammation2014